Literature DB >> 22663564

Proteomic analysis of bronchoalveolar lavage fluid proteins from mice infected with Francisella tularensis ssp. novicida.

Susan M Varnum1, Bobbie-Jo M Webb-Robertson, Joel G Pounds, Ronald J Moore, Richard D Smith, Charles W Frevert, Shawn J Skerrett, David Wunschel.   

Abstract

Francisella tularensis causes the zoonosis tularemia in humans and is one of the most virulent bacterial pathogens. We utilized a global proteomic approach to characterize protein changes in bronchoalveolar lavage fluid from mice exposed to one of three organisms, F. tularensis ssp. novicida, an avirulent mutant of F. tularensis ssp. novicida (F.t. novicida-ΔmglA), and Pseudomonas aeruginosa. The composition of bronchoalveolar lavage fluid (BALF) proteins was altered following infection, including proteins involved in neutrophil activation, oxidative stress, and inflammatory responses. Components of the innate immune response were induced including the acute phase response and the complement system; however, the timing of their induction varied. F. tularensis ssp. novicida infected mice do not appear to have an effective innate immune response in the first hours of infection; however, within 24 h, they show an upregulation of innate immune response proteins. This delayed response is in contrast to P. aeruginosa infected animals which show an early innate immune response. Likewise, F.t. novicida-ΔmglA infection initiates an early innate immune response; however, this response is diminished by 24 h. Finally, this study identifies several candidate biomarkers, including Chitinase 3-like-1 (CHI3L1 or YKL-40) and peroxiredoxin 1, that are associated with F. tularensis ssp. novicida but not P. aeruginosa infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22663564      PMCID: PMC3423085          DOI: 10.1021/pr3001767

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  76 in total

1.  Transcriptional profiling of the peripheral blood response during tularemia.

Authors:  H Andersson; B Hartmanová; E Bäck; H Eliasson; M Landfors; L Näslund; P Rydén; A Sjöstedt
Journal:  Genes Immun       Date:  2006-07-06       Impact factor: 2.676

2.  Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury.

Authors:  Lynn M Schnapp; Samuel Donohoe; Jinzhi Chen; Donald A Sunde; Patricia M Kelly; John Ruzinski; Thomas Martin; David R Goodlett
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Defect in efferocytosis leads to alternative activation of macrophages in Francisella infections.

Authors:  Chris A Mares; Jyotika Sharma; Qun Li; Edward L Rangel; Elizabeth G Morris; Melissa I Enriquez; Judy M Teale
Journal:  Immunol Cell Biol       Date:  2010-06-29       Impact factor: 5.126

4.  Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors.

Authors:  Adeline M Hajjar; Megan D Harvey; Scott A Shaffer; David R Goodlett; Anders Sjöstedt; Helen Edebro; Mats Forsman; Mona Byström; Mark Pelletier; Christopher B Wilson; Samuel I Miller; Shawn J Skerrett; Robert K Ernst
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

Review 5.  Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease.

Authors:  Betty S van der Veen; Menno P J de Winther; Peter Heeringa
Journal:  Antioxid Redox Signal       Date:  2009-11       Impact factor: 8.401

6.  Differential regulation of membrane CD14 expression and endotoxin-tolerance in alveolar macrophages.

Authors:  Shu-Min Lin; Charles W Frevert; Osamu Kajikawa; Mark M Wurfel; Kimberly Ballman; Stephen Mongovin; Venus A Wong; Amy Selk; Thomas R Martin
Journal:  Am J Respir Cell Mol Biol       Date:  2004-04-01       Impact factor: 6.914

7.  Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns.

Authors:  Chris A Mares; Sandra S Ojeda; Elizabeth G Morris; Qun Li; Judy M Teale
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

Review 8.  Structure, mechanism and regulation of peroxiredoxins.

Authors:  Zachary A Wood; Ewald Schröder; J Robin Harris; Leslie B Poole
Journal:  Trends Biochem Sci       Date:  2003-01       Impact factor: 13.807

9.  Of mice and men: comparative proteomics of bronchoalveolar fluid.

Authors:  S A Gharib; E Nguyen; W A Altemeier; S A Shaffer; C E Doneanu; D R Goodlett; L M Schnapp
Journal:  Eur Respir J       Date:  2009-12-23       Impact factor: 16.671

Review 10.  Lactoferrin: a modulator of immune and inflammatory responses.

Authors:  D Legrand; E Elass; M Carpentier; J Mazurier
Journal:  Cell Mol Life Sci       Date:  2005-11       Impact factor: 9.261

View more
  3 in total

1.  Loss of SP-A in the Lung Exacerbates Pulmonary Fibrosis.

Authors:  Kyunghwa Kim; Dasom Shin; Gaheon Lee; Hyunsu Bae
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

2.  Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure.

Authors:  Matthew W Foster; J Will Thompson; Loretta G Que; Ivana V Yang; David A Schwartz; M Arthur Moseley; Harvey E Marshall
Journal:  J Proteome Res       Date:  2013-04-24       Impact factor: 4.466

3.  Inactivation of Peroxiredoxin 6 by the Pla Protease of Yersinia pestis.

Authors:  Daniel L Zimbler; Justin L Eddy; Jay A Schroeder; Wyndham W Lathem
Journal:  Infect Immun       Date:  2015-11-09       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.